Discussing PsA: Difficult-to-manage PsA and molecular/clinical responses to zasocitinib
Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...
15 Loka 17min
Disusisng PsA Sept - Audio only
Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...
15 Loka 17min
Discussing RA: Impact of BMI on response to JAK inhibitors in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review paper by Bechman et al. where he highlights the i...
8 Loka 7min
Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials
Join Dr Sofia Ramiro and Dr Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered whether men and women with axSpA respond differently to bimeki...
30 Syys 20min
Author Interview: Doctor Elise van Mulligen, September 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Lo...
3 Syys 21min
Discussing RA: Biologic effectiveness and treatment persistence in RA
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et a...
27 Elo 8min
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...
20 Elo 24min
